A comparison of the Thrombelastograph and the ROTEM

Elastic modulus-based assessment of hemostasis in clinical and research settings has been conducted for nearly 60 years. Two systems utilizing this technology include the Thrombelastograph (Haemoscope Corporation, Niles, Illinois, USA) and the ROTEM (Pentapharm GmbH, Munich, Germany). The study goal was to compare the Thrombelastograph and the ROTEM to determine whether differences in data could be detected. Plasma (n = 8 per condition) was not activated (native); was celite-activated, hypocoagulable by dilution with hydroxyethyl starch; was celite-activated, normal; and was celite-activated, hypercoagulable by addition of fibrinogen. Equivalent ratios of plasma mixture to CaCl2 were maintained between the Thrombelastograph and ROTEM systems. Data collected included the reaction time, angle, maximum amplitude and maximum elastic modulus. The ROTEM system generated significantly (P < 0.05) smaller reaction time (mean ± SD, 459 ± 39 versus 788 ± 94 s) and greater angle (60.1 ± 5.3 versus 46.4 ± 4.6°), maximum amplitude (27.6 ± 1.6 versus 24.4 ± 1.4 mm) and maximum elastic modulus (1911 ± 152 versus 1616 ± 121 dynes/cm2) values with native plasma compared with the Thrombelastograph. Celite-activation tended to attenuate differences between the two systems. In conclusion, a comparison of the Thrombelastograph and the ROTEM with similar samples demonstrated clinically significant differences in the data generated without exogenous activation. Given these data and the differences in proprietary activator, divergent results are expected, perhaps affecting clinical decision-making.

[1]  Brad L Steenwyk,et al.  Qualitative Thrombelastographic Detection of Tissue Factor in Human Plasma , 2007, Anesthesia and analgesia.

[2]  L. W. Andersen,et al.  Use of thromboelastograph and factor VII for the treatment of postoperative bleeding in a pediatric patient on ECMO after cardiac surgery. , 2006, The journal of extra-corporeal technology.

[3]  M. Mythen,et al.  Just scratching the surface: varied coagulation effects of polymer containers on TEG variables , 2006, European journal of anaesthesiology.

[4]  D. O'shaughnessy,et al.  Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. , 2005, British journal of anaesthesia.

[5]  V. Nielsen.  Effects of PentaLyte® and Voluven® hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin‐fibrinogen and factor XIII‐fibrin polymer interactions , 2005, Acta anaesthesiologica Scandinavica.

[6]  J. Hentz,et al.  A Comparison of Transfusion Requirements Between Living Donation and Cadaveric Donation Liver Transplantation: Relationship to Model of End-Stage Liver Disease Score and Baseline Coagulation Status , 2005, Anesthesia and analgesia.

[7]  V. Nielsen.  Antithrombin efficiency is maintained in vitro in human plasma following dilution with hydroxyethyl starches , 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  B. M. Cohen,et al.  Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography®: critical roles of fibrinogen and factors II, VII, X and XII , 2005, Acta anaesthesiologica Scandinavica.

[9]  H. Hartert,et al.  Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren , 1948, Klinische Wochenschrift.

[10]  M. Rizzetto,et al.  Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  M. DePerio,et al.  Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. , 1999, Anesthesia and analgesia.